Author Question: Among the two types of between-groups designs, it is easier to protect the confidentiality of ... (Read 61 times)

serike

  • Hero Member
  • *****
  • Posts: 542
Among the two types of between-groups designs, it is easier to protect the confidentiality of responses of the participants in the posttest-only control group design.
 
  Indicate whether the statement is true or false

Question 2

Maurice is a counselor in training interested in using Perl's gestalt theory with his clients. Which of the following is NOT likely to take place early on his work with his clients?
 
  a. Developing his working counseling relationship with clients using empathy and unconditional positive regard.
  b. Confirmation of the client's unique self while simultaneously expressing his (the counselor's) authentic self.
  c. Assessing his client's ability to make authentic contact with others and the environment.
  d. Assisting the client to identify polarities and shoulds.



coyin

  • Sr. Member
  • ****
  • Posts: 334
Answer to Question 1

True

Answer to Question 2

A



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

coyin

  • Sr. Member
  • ****
  • Posts: 334

 

Did you know?

Never take aspirin without food because it is likely to irritate your stomach. Never give aspirin to children under age 12. Overdoses of aspirin have the potential to cause deafness.

Did you know?

Vampire bats have a natural anticoagulant in their saliva that permits continuous bleeding after they painlessly open a wound with their incisors. This capillary blood does not cause any significant blood loss to their victims.

Did you know?

Drying your hands with a paper towel will reduce the bacterial count on your hands by 45–60%.

Did you know?

More than 34,000 trademarked medication names and more than 10,000 generic medication names are in use in the United States.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library